Pricing

Annexon Biosciences

2 followers

‌

Annexon is a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative, and ophthalmic disorders of the body, brain, and eye.

Industries

Biotechnology, Health & Wellness

Headquarters

South San Francisco, United States

Employees

51-200

Links

Org chart

Douglas Love

President & Chief Executive Officer

Collapse

Michael Overdorf

EVP & Chief Business Officer

Rick Artis

Chief Scientific Officer

Jennifer Lew

EVP & Chief Financial Officer

Ted Yednock

EVP & Chief Innovation Officer

Dean Richard Artis

EVP And Chief Scientific Officer

Jamie Dananberg

EVP & Chief Medical Officer

AJ Acker

Senior Vice President, Regulatory, Quality & Clinical Safety

Cecilia Oliyai

Senior Vice President CMC Operations

John Hanna

VP & Head of Clinical Safety

Peter Collins

Vp, Global Program Team Lead - Neurodegeneration Franchise

Kunal Kanani

Vice President Regulatory Affairs

Board & advisors

Thomas G. Wiggans

Board Member

William H. Carson

Board Member

Jung E. Choi

Board Member, Compensation Committee Chair, Science & Technology Committee

Board Member

Board Member

Scientific Advisor

Scientific Advisor

Scientific Advisor

Scientific Advisor

Scientific Advisor

Scientific Advisor

Board Member

Teams

+14

Clinical Development and Operations

18 people · 0 jobs

Leadership Team

4 people · 0 jobs

Offices

HQ
28 positions, 2 job posts
VT
+24

Similar companies

Sutro Biopharma

3 followers

Esalen

3 followers

Active Motif

3 followers

Dyno Therapeutics

4 followers

Janux Therapeutics

1 follower

Onnit

1 follower

Cylinder

18 followers

Insight Timer

2 followers

Amicus Therapeutics

4 followers

Eikon Therapeutics

3 followers

Bioptimizers

4 followers

Explore companies